Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m641 · Cited by 727

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Section of Precision Medicine Group of Chinese Society of Cardiology, Wang, D. W., Editorial Board of Chinese Journal of Cardiology, Working Group of Adult Fulminant Myocarditis, Li, S., Jiang, J., Yan, J., Zhao, C., Wang, Y., Ye-xin, M., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9385-3 · Cited by 128

SARS-CoV-2 involvement in central nervous system tissue damage

Sabra, M., Kobeissy, F. H., Bizri, M., Haidar, M. A., Shakkour, Z., Reslan, M. A., Al-Haj, N., Chamoun, P., Habashy, K. J., Kaafarani, H., et al. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.327323 · Cited by 58

COVID-19 vs. Classical Myocarditis Associated Myocardial Injury Evaluated by Cardiac Magnetic Resonance and Endomyocardial Biopsy

Tanacli, R., Doeblin, P., Götze, C., Zieschang, V., Faragli, A., Stehning, C., Korosoglou, G., Erley, J., Weiß, K. J., Berger, A., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.737257 · Cited by 57

Comprehensive Landscape of Heparin Therapy for COVID-19

Shi, C., Wu, T., Li, J.-P., Sullivan, M. A., Wang, C., Wang, H., Deng, B., & Zhang, Y. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117232 · Cited by 59

Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line

Navarro, K. M., Clark, K. A., Hardt, D. J., Reid, C. E., Lahm, P. W., Domitrovich, J. W., Butler, C., & Balmes, J. R. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.144296 · Cited by 58

Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial

Tornling, G., Batta, R., Porter, J. C., Williams, B., Bengtsson, T., Parmar, K., Kashiva, R., Hallberg, A., Cohrt, A. K., Westergaard, K., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101152 · Cited by 54

Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation

Asfahan, S., Deokar, K. K., Dutt, N., Niwas, R., Jain, P., & Agarwal, M. (2020) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2020.1325 · Cited by 55

Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients

Convertino, I., Tuccori, M., Ferraro, S., Valdiserra, G., Cappello, E., Focosi, D., & Blandizzi, C. (2020) · Critical Care · doi:10.1186/s13054-020-03020-3 · Cited by 55

Gastrointestinal and hepatic manifestations of Corona Virus Disease-19 and their relationship to severe clinical course: A systematic review and meta-analysis

Kumar, A., Arora, A., Sharma, P., Anikhindi, S. A., Bansal, N. K., Singla, V., Khare, S., & Srivastava, A. (2020) · Indian Journal of Gastroenterology · doi:10.1007/s12664-020-01058-3 · Cited by 55

Multidisciplinary Guidance Regarding the Use of Immunomodulatory Therapies for Acute Coronavirus Disease 2019 in Pediatric Patients

Dulek, D. E., Fuhlbrigge, R. C., Tribble, A. C., Connelly, J. A., Loi, M. M., Chebib, H. E., Chandrakasan, S., Otto, W. R., Diorio, C. J., Keim, G. P., et al. (2020) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaa098 · Cited by 56

Assessment of Clinical Characteristics and Mortality-Associated Factors in COVID-19 Critical Cases in Kuwait

Ayed, M., Borahmah, A. A., Yazdani, A., Sultan, A., Mossad, A., & Rawdhan, H. (2020) · Medical Principles and Practice · doi:10.1159/000513047 · Cited by 55

Impact of viral load at admission on the development of respiratory failure in hospitalized patients with SARS-CoV-2 infection

de la Calle, C., Lalueza, A., Mancheño‐Losa, M., de la Calle, G. M., Lora‐Tamayo, J., Arrieta, E., García‐Reyne, A., Losada, I., de Miguel, B., Díaz‐Simón, R., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04150-w · Cited by 55

Cardiovascular sequalae in uncomplicated COVID-19 survivors

Zhou, M., Wong, C., Un, K., Lau, Y.-M., Lee, J. C.-Y., Tam, F. C.-C., Lau, Y., Lai, W., Tam, A. R., Lam, Y., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246732 · Cited by 55

Sex Differences on Clinical Characteristics, Severity, and Mortality in Adult Patients With COVID-19: A Multicentre Retrospective Study

Sha, J., Qie, G., Yao, Q., Sun, W., Wang, C., Zhang, Z., Wang, X., Wang, P., Jiang, J., Bai, X., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.607059 · Cited by 55

Prevalence of Obesity and Its Impact on Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis

Helvacı, N., Eyüpoğlu, D., Karabulut, E., & Yıldız, B. O. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.598249 · Cited by 55

Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study

collaborators, Robba, C., Ball, L., Battaglini, D., Cardim, D., Moncalvo, E., Brunetti, I., Bassetti, M., Giacobbe, D. R., Vena, A., et al. (2021) · Critical Care · doi:10.1186/s13054-021-03537-1 · Cited by 55

A Machine-Generated View of the Role of Blood Glucose Levels in the Severity of COVID-19

Logette, E., Lorin, C., Favreau, C., Oshurko, E., Coggan, J. S., Casalegno, F., Sy, M. F., Monney, C., Bertschy, M., Delattre, É., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.695139 · Cited by 58

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

Soraya, G. V., & Ulhaq, Z. S. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.05.004 · Cited by 55

The Future Landscape of Macrophage Research in Cardiovascular Disease: A Bibliometric Analysis

Xu, X., Wang, Y., Li, Y., Zhang, B., & Song, Q. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101311 · Cited by 55

Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters

Delval, L., Hantute-Ghesquier, A., Sencio, V., Flaman, J., Robil, C., Angulo, F. S., Lipskaia, L., Çobanoglu, Ö., Lacoste, A., Machelart, A., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00442-w · Cited by 58

CORONAVIRUS DISEASE 2019 (COVID-19): A RHEUMATOLOGIST’S THOUGHTS

Nasonov, E. L. (2020) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2020-123-132 · Cited by 59

TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2

Kaushik, D., Bhandari, R., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1918103 · Cited by 59

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

Ekholm, M., & Kahan, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640185 · Cited by 62

COVID-19 Mortality Risk Assessment: An International Multi-Center StudyPreprint

Bertsimas, D., Lukin, G., Mingardi, L., Nohadani, O., Orfanoudaki, A., Stellato, B., Wiberg, H., González-García, S., Parra-Calderón, C. L., The Hellenic COVID-19 Study Group, et al. (2020) · medRxiv · doi:10.1101/2020.07.07.20148304 · Cited by 55

SARS-CoV-2 and COVID-19: facing the pandemic together as citizens and cardiovascular practitioners

Biondi‐Zoccai, G., Landoni, G., Carnevale, R., Cavarretta, E., Sciarretta, S., & Frati, G. (2020) · Minerva Cardioangiologica · doi:10.23736/s0026-4725.20.05250-0 · Cited by 54

Platelets in Coronavirus Disease 2019

Larsen, J. B., Pasalic, L., & Hvas, A. (2020) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0040-1710006 · Cited by 54

Coronavirus Disease 2019: Clinical Review

Gouveia, C. C., & Campos, L. (2020) · Acta Médica Portuguesa · doi:10.20344/amp.13957 · Cited by 56

Immune Immunomodulation in Coronavirus Disease 2019 (COVID-19): Strategic Considerations for Personalized Therapeutic Intervention

Hall, M. W., Joshi, I., Leal, L. O., & Ooi, E. E. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa904 · Cited by 54

Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression

Khinda, J., Janjua, N. Z., Cheng, S. S. Y., van den Heuvel, E. R., Bhatti, P., & Darvishian, M. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26411 · Cited by 53

Observational study of haloperidol in hospitalized patients with COVID-19

Hoertel, N., Rico, M. S., Vernet, R., Jannot, A., Neuraz, A., Blanco, C., Lemogne, C., Airagnes, G., Paris, N., Daniel, C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247122 · Cited by 57

HGF, IL-1α, and IL-27 Are Robust Biomarkers in Early Severity Stratification of COVID-19 Patients

Tamayo-Velasco, Á., Martínez-Paz, P., Peñarrubia-Ponce, M. J., de la Fuente, I., González, S. P., Fernández, I., Dueñas, C., Gómez‐Sánchez, E., Lorenzo‐López, M., Gómez‐Pesquera, E., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10092017 · Cited by 55

Cardiovascular disease in SARS‐CoV‐2 infection

Sato, K., Sinclair, J. E., Sadeghirad, H., Fraser, J. F., Short, K. R., & Kulasinghe, A. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1343 · Cited by 52

Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis

Hu, H., Pan, H., Li, R., He, K., Zhang, H., & Liu, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.802228 · Cited by 54

Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review

Mehta, J., Rolta, R., Mehta, B. B., Kaushik, N., Choi, E. H., & Kaushik, N. K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.813358 · Cited by 62

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Feyaerts, D., Hedou, J. J., Gillard, J., Chen, H. M., Tsai, E. S., Peterson, L. S., Ando, K., Manohar, M., Do, E., Dhondalay, G. K., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100680 · Cited by 56

Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

Labarrere, C. A., & Kassab, G. S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.979719 · Cited by 56

Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis

Salama, H., Jazieh, A. R., Alhejazi, A., Absi, A., Alshieban, S., Alzahrani, M., Alaskar, A. S., Gmati, G. E. M., Damlaj, M., Abuelgasim, K. A., et al. (2020) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2020.08.007 · Cited by 54

COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country

Licciardi, F., Giani, T., Baldini, L., Favalli, E. G., Caporali, R. F., & Cimaz, R. (2020) · Pediatric Rheumatology · doi:10.1186/s12969-020-00422-z · Cited by 53

Three months of COVID ‐19: A systematic review and meta‐analysis

Rafiq, D., Batool, A., & Bazaz, M. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2113 · Cited by 53

Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system

Watson, R. A., Johnson, D. M., Dharia, R. N., Merli, G. J., & Doherty, J. U. (2020) · Hospital Practice · doi:10.1080/21548331.2020.1772639 · Cited by 55

SARS-CoV-2/COVID-19: Evolving Reality, Global Response, Knowledge Gaps, and Opportunities

Osuchowski, M. F., Aletti, F. M., Cavaillon, J., Flohé, S. B., Giamarellos‐Bourboulis, E. J., Huber-Lang, M. S., Relja, B., Skirecki, T., Szabó, A., & Maegele, M. (2020) · Shock · doi:10.1097/shk.0000000000001565 · Cited by 50

Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium

Bristow, M. R., Zisman, L. S., Altman, N. L., Gilbert, E. M., Lowes, B. D., Minobe, W. A., Slavov, D. B., Schwisow, J. A., Rodriguez, E. M., Carroll, I. A., et al. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.06.007 · Cited by 53

COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease

Gan, R., Rosoman, N., Henshaw, D. J. E., Noble, E. P., Georgius, P., & Sommerfeld, N. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110024 · Cited by 53

The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure

Keith, P. D., Day, M. S., Choe, C. H., Perkins, L., Moyer, L., Hays, E., French, M., Hewitt, K., Gravel, G., Guffey, A., et al. (2020) · SAGE Open Medical Case Reports · doi:10.1177/2050313x20933473 · Cited by 53

Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies

Parohan, M., Yaghoubi, S., & Seraji, A. (2020) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872620937165 · Cited by 53

Usefulness of echocardiography to detect cardiac involvement in COVID‐19 patients

Cameli, M., Pastore, M. C., Soliman-Aboumarie, H., Mandoli, G. E., D’Ascenzi, F., Cameli, P., Bigio, E., Franchi, F., Mondillo, S., & Valente, S. (2020) · Echocardiography · doi:10.1111/echo.14779 · Cited by 52

Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection

Hou, X., Zhang, X., Wu, X. Z., Lu, M., Wang, D., Xu, M., Wang, H., Liang, T., Dai, J., Duan, H., et al. (2020) · Molecular & Cellular Proteomics · doi:10.1074/mcp.rp120.002128 · Cited by 56

Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients

Marcos‐Jiménez, A., Sánchez‐Alonso, S., Alcaraz‐Serna, A., Esparcia, L., López‐Sanz, C., Sampedro-Nuñez, M. A., Mateu‐Albero, T., Sánchez‐Cerrillo, I., Martínez‐Fleta, P., Gabrie, L., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048858 · Cited by 52

Modeling and simulations of CoViD-19 molecular mechanism induced by cytokines storm during SARS-CoV2 infection

Yu, Z., Ellahi, R., Nutini, A., Sohail, A., & Sait, S. M. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114863 · Cited by 53

When Does the Cytokine Storm Begin in COVID-19 Patients? A Quick Score to Recognize It

Cappanera, S., Palumbo, M., Kwan, S. H., Priante, G., Martella, L. A., Saraca, L. M., Sicari, F., Vernelli, C., Giuli, C. D., Andreani, P., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020297 · Cited by 50

Exercise, Immune System, Nutrition, Respiratory and Cardiovascular Diseases during COVID-19: A Complex Combination

Scudiero, O., Lombardo, B., Brancaccio, M., Mennitti, C., Cesaro, A., Fimiani, F., Gentile, L., Moscarella, E., Amodio, F., Ranieri, A., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030904 · Cited by 52

Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted

Borah, P., Deb, P. K., Chandrasekaran, B., Goyal, M., Bansal, M., Hussain, S., Shinu, P., Venugopala, K. N., Al‐Shar’i, N. A., Deka, S., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.627723 · Cited by 53

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia: A Randomized Double-Blind Study

Papachristofilou, A., Finazzi, T., Blum, A., Zehnder, T., Zellweger, N. M., Lustenberger, J., Bauer, T., Dott, C., Avcu, Y., Kohler, G., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.02.054 · Cited by 54

Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan, China

Liu, X., Xue, S., Xu, J., Ge, H., Mao, Q., Xu, X., & Jiang, H. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00627-2 · Cited by 53

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

The Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent, C., Windecker, S., Andreini, D., Arbelo, E., Barbato, E., Bartorelli, A. L., Baumbach, A., Behr, E. R., Berti, S. L., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab343 · Cited by 53

Antiinflammatory potential of nano‐curcumin as an alternative therapeutic agent for the treatment of mild‐to‐moderate hospitalized COVID‐19 patients in a placebo‐controlled clinical trial

Asadirad, A., Nashibi, R., Khodadadi, A., Ghadiri, A., Sadeghi, M., Aminian, A., & Dehnavi, S. (2022) · Phytotherapy Research · doi:10.1002/ptr.7375 · Cited by 54

Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies

Berlansky, S., Sallinger, M., Grabmayr, H., Humer, C., Bernhard, A., Fahrner, M., & Frischauf, I. (2022) · Cells · doi:10.3390/cells11020253 · Cited by 52

Cardiovascular disease and COVID-19: les liaisons dangereuses

Barison, A., Aimo, A., Castiglione, V., Arzilli, C., Lupón, J., Codina, P., Santiago‐Vacas, E., Cediel, G., Emdin, M., & Bayés‐Genís, A. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320924501 · Cited by 56

Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series

Singh, S., Chakravarty, T., Chen, P., Akhmerov, A., Falk, J., Friedman, O., Zaman, T., Ebinger, J. E., Gheorghiu, M., Marbán, L., et al. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0795-1 · Cited by 52

Recent Insight into SARS-CoV2 Immunopathology and Rationale for Potential Treatment and Preventive Strategies in COVID-19

Lega, S., Naviglio, S., Volpi, S., & Tommasini, A. (2020) · Vaccines · doi:10.3390/vaccines8020224 · Cited by 56

Understanding the COVID‐19 coagulopathy spectrum

Thachil, J. V., & Agarwal, S. (2020) · Anaesthesia · doi:10.1111/anae.15141 · Cited by 51

Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection

Fialkowski, A., Gernez, Y., Arya, P., Weinacht, K. G., Kinane, T. B., & Yonker, L. M. (2020) · Pediatric Pulmonology · doi:10.1002/ppul.24981 · Cited by 52

Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol

Capochiani, E., Frediani, B., Iervasi, G., Paolicchi, A., Sani, S., Roncucci, P., Cuccaro, A., Franchi, F., Simonetti, F., Carrara, D., et al. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00466 · Cited by 52

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)

Sheng, C. C., Sahoo, D. H., Dugar, S. P., Prada, R. A., Wang, T. K. M., Hassan, O. K. A., Brennan, D. M., Culver, D. A., Rajendram, P., Duggal, A., et al. (2020) · Clinical Cardiology · doi:10.1002/clc.23451 · Cited by 51

History of coronary heart disease increased the mortality rate of patients with COVID-19: a nested case–control study

Gu, T., Chu, Q., Yu, Z., Fa, B., Li, A., Xu, L., He, Y., & Wu, R. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038976 · Cited by 55

COVID-19 during Pregnancy and Postpartum:

Naidu, S. A. G., Clemens, R., Pressman, P., Zaigham, M., Kadkhoda, K., Davies, K. J. A., & Naidu, A. S. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1834049 · Cited by 57

Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study

Falcone, M., Tiseo, G., Barbieri, G., Galfo, V., Russo, A., Virdis, A., Forfori, F., Corradi, F., Guarracino, F., Carrozzi, L., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa563 · Cited by 52

Novel coronavirus disease (COVID-19) pandemic: A recent mini review

Rehman, M. F. U., Fariha, C., Anwar, A., Shahzad, N., Ahmad, M., Mukhtar, S., & Haque, M. F. U. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.033 · Cited by 58

IL-6 modulation for COVID-19: the right patients at the right time?

Ascierto, P. A., Fu, B., & Wei, H. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002285 · Cited by 50

Predicting Severity and Intrahospital Mortality in COVID‐19: The Place and Role of Oxidative Stress

Čekerevac, I., Turnic, T. N., Draginic, N. D., Andjic, M. M., Zivkovic, V. I., Simovic, S. M., Suša, R., Novković, L., Mijailović, Ž., Andjelkovic, M. V., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6615787 · Cited by 54

Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings

Cultrera, R., Barozzi, A., Libanore, M., Marangoni, E., Pora, R., Quarta, B., Spadaro, S., Ragazzi, R., Marra, A. R., Segala, D., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18084358 · Cited by 50

Current Status of Baricitinib as a Repurposed Therapy for COVID-19

Saber-Ayad, M. M., Hammoudeh, S. M., Abu‐Gharbieh, E., Hamoudi, R., Tarazi, H., Al‐Tel, T. H., & Hamid, Q. A. (2021) · Pharmaceuticals · doi:10.3390/ph14070680 · Cited by 55

Early and late endocrine complications of COVID-19

Kazakou, P., Paschou, S. Α., Ψαλτοπούλου, Θ., Gavriatopoulou, M., Korompoki, E., Stefanaki, K., Kanouta, F., Kassi, G., Dimopoulos, M. A., & Mitrakou, A. (2021) · Endocrine Connections · doi:10.1530/ec-21-0184 · Cited by 56

COVID‐19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives

Esposito, L., Cancro, F. P., Silverio, A., Maio, M. D., Iannece, P., Damato, A., Alfano, C., Luca, G. D., Vecchione, C., & Galasso, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4936571 · Cited by 64

Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital

Silva, A. R. O., Salgado, D. R., Lopes, L. P. N., Castanheira, D., Emmerick, I. C. M., & Lima, E. D. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778386 · Cited by 57

Links between COVID-19 and Alzheimer’s Disease—What Do We Already Know?

Rudnicka-Drożak, E., Drożak, P., Mizerski, G., Zaborowski, T., Ślusarska, B. J., Nowicki, G., & Drożak, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032146 · Cited by 57

Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months

Santopaolo, M., Gregorová, M., Hamilton, F., Arnold, D., Long, A. E., Lacey, A., Oliver, E., Halliday, A., Baum, H. E., Hamilton, K., et al. (2023) · eLife · doi:10.7554/elife.85009 · Cited by 56

Potential Application of Whole Body Vibration Exercise for Improving the Clinical Conditions of COVID-19 Infected Individuals: A Narrative Review from the World Association of Vibration Exercise Experts (WAVex) Panel

Sañudo, B., Seixas, A., Gloeckl, R., Rittweger, J., Rawer, R., Taïar, R., van der Zee, E. A., van Heuvelen, M. J. G., Lacerda, A. C. R., Sartório, A., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17103650 · Cited by 56

Nanomedicine therapies modulating Macrophage Dysfunction: a potential strategy to attenuate Cytokine Storms in severe infections

Liu, J., Wan, M., Lyon, C. J., & Hu, Y. (2020) · Theranostics · doi:10.7150/thno.47982 · Cited by 53

Prognostic value of cardiac biomarkers in COVID-19 infection

Sheth, A. R., Modi, M., Dawson, D., & Dominic, P. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-84643-6 · Cited by 52

Implications of COVID-19 in pediatric rheumatology

Batu, E. D., & Özen, S. (2020) · Rheumatology International · doi:10.1007/s00296-020-04612-6 · Cited by 52

American Heart Association COVID-19 CVD Registry Powered by Get With The Guidelines

Alger, H. M., Rutan, C. M., Williams, J. H., Walchok, J. G., Bolles, M. M., Hall, J. L., Bradley, S. M., Elkind, M. S. V., Rodríguez, F., Wang, T. Y., et al. (2020) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006967 · Cited by 51

COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study

Alsharidah, S. I., Ayed, M., Ameen, R. M., Alhuraish, F., Rouheldeen, N. A., Alshammari, F. R., Embaireeg, A., Almelahi, M., Adel, M., Dawoud, M. E., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.198 · Cited by 51

Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection

Zanza, C., Racca, F., Longhitano, Y., Piccioni, A., Franceschi, F., Artico, M., Abenavoli, L., Maiese, A., Passaro, G., Volonnino, G., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031268 · Cited by 52

Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients

Han, M., Ma, K., Wang, X., Yan, W., Wang, H., You, J., Wang, Q., Chen, H., Guo, W., Chen, T., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.596518 · Cited by 48

Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran

Sohrabi, M.-R., Amin, R., Maher, A., Bahadorimonfared, A., Janbazi, S., Hannani, K., Kolahi, A., & Zali, A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06179-4 · Cited by 49

Epidemiological Characteristics and Forecast of COVID-19 Outbreak in the Republic of Kazakhstan

Semenova, Y. M., Glushkova, N., Pivina, L. M., Khismetova, Z. A., Е.Т., Ж., Сандыбаев, М. Н., & Ivankov, A. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e227 · Cited by 51

SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches—Insights into Chemical Structure—Biological Activity and Toxicological Screening

Dehelean, C. A., Lăzureanu, V. E., Coricovac, D. E., Mioc, M., Oancea, R., Marcovici, I., Pînzaru, I., Şoica, C., Tsatsakis, A. M., & Cretu, O. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072084 · Cited by 53

The evolving obesity challenge: targeting the vagus nerve and the inflammatory reflex in the response

Pavlov, V. A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107794 · Cited by 50

Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production

Wang, X.-T., Peng, Z., An, Y.-Y., Shang, T., Xiao, G., He, S., Chen, X., Zhang, H., Wang, Y., Wang, T., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.614024 · Cited by 51

Arterial hypertension and the risk of severity and mortality of COVID-19

Sisnieguez, C. E. L., Espeche, W. G., & Salazar, M. R. (2020) · European Respiratory Journal · doi:10.1183/13993003.01148-2020 · Cited by 51

Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation

Cardone, M., Yano, M., Rosenberg, A. S., & Puig, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01131 · Cited by 49

High mortality in COVID‐19 patients with mild respiratory disease

Masetti, C., Generali, E., Colapietro, F., Voza, A., Cecconi, M., Messina, A., Omodei, P., Angelini, C., Ciccarelli, M., Badalamenti, S., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13314 · Cited by 50

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect

Can, A., & Coskun, H. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0164 · Cited by 49

Elevated interleukin levels are associated with higher severity and mortality in COVID 19 – A systematic review, meta-analysis, and meta-regression

Yonas, E., Alwi, I., Pranata, R., Huang, I., Lim, M. A., Yamin, M., Nasution, S. A., Setiati, S., & Virani, S. S. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.11.011 · Cited by 50

Role of biochemical markers in the monitoring of COVID-19 patients

Letelier, P. J., Encina, N. A. M., Morales, P., Riffo, A., Silva, H., Riquelme, I., & Guzmán, N. H. (2020) · Journal of Medical Biochemistry · doi:10.5937/jomb0-29341 · Cited by 54

Long Noncoding RNAs as Emerging Regulators of COVID-19

Yang, Q., Fang, L., Wang, Y., Min De, Z. E. N. G., & Luo, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.700184 · Cited by 51

A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis

Adeboye, A. A., Alkhatib, D. A., Butt, A. K., Yedlapati, N., & Garg, N. (2022) · Diagnostics · doi:10.3390/diagnostics12020549 · Cited by 52

Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies

Mbatha, L. S., Akinyelu, J., Chukwuma, C. I., Mokoena, M. P., & Kudanga, T. (2023) · Viruses · doi:10.3390/v15030741 · Cited by 54

Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID

Scott, N. A., Pearmain, L., Knight, S., Brand, O. J., Morgan, D. J., Jagger, C. P., Harbach, S. L., Khan, S., Shuwa, H. A., Franklin, M., et al. (2023) · European Respiratory Journal · doi:10.1183/13993003.02226-2022 · Cited by 49

IL1β, IL-6, and TNF-α cytokines cooperate to modulate a complicated medical condition among COVID-19 patients: case-control study

Faraj, S. S., & Jalal, P. J. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000679 · Cited by 50

Relative Lymphocytosis in COVID-19—A Ray of Hope

Ish, P., Malhotra, N., Agrawal, S. P., & Gupta, N. (2020) · Advances in respiratory medicine · doi:10.5603/arm.a2020.0098 · Cited by 11

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Wang, K., Zhang, Z., Yu, M., Tao, Y., & Xie, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06047-w · Cited by 87

Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective StudyPreprint

Zhang, S., Guo, M., Duan, L., Wu, F., Wang, Z., Xu, J., Ma, Y., Lv, Z., Tan, X., Zhang, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551390 · Cited by 8

“Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.” Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng and Huan-Zhong Shi. Eur Respir J 2020; 55: 2000524.

European Respiratory Society (2020) · European Respiratory Journal · doi:10.1183/13993003.50524-2020 · Cited by 18

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su, M., Yuan, J., Peng, J., Wu, M., Yang, Y., & Peng, Y. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.109927 · Cited by 5